Deep Track Capital’s Solid Biosciences SLDB Stock Holding History

Deep Track Capital’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.6M	Hold	3,565,062	–	–	0.52%	45
2026 Q1	$25.7M	Buy	+3,565,062	New	+$22.9M	0.42%	48

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deep Track Capital's SLDB Position: Q2 2026 in Review

Deep Track Capital held its Solid Biosciences (SLDB) position steady in Q2 2026 at 3,565,062 shares worth $35.6M. The position accounts for 0.52% of the portfolio, ranked #45.

Deep Track Capital first reported a position in SLDB in Q1 2026 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Deep Track Capital held 3,565,062 shares of Solid Biosciences worth $35.6M as of Q2 2026.
Deep Track Capital left its Solid Biosciences share count unchanged in Q2 2026.
Solid Biosciences made up 0.52% of Deep Track Capital's portfolio in Q2 2026, its #45 holding.
Deep Track Capital first reported a position in Solid Biosciences in Q1 2026 and has held it in 2 quarters since.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.